valsartan has been researched along with Postoperative Complications in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, P; Jin, D; Ke, Z; Wu, Y; Zhang, K; Zhang, Y | 1 |
| Koehler, B; Peters, S; Rählert-Sommer, A; Selbig, D; Steffen, H; Trümmel, M | 1 |
| Hollomby, DJ; House, A; Jevnikar, AM; Muirhead, N | 1 |
| Andrés, A; Bosch, I; Campo, C; Morales, E; Morales, JM; Ruilope, LM | 1 |
| Coleman, CI; Kluger, J; Makanji, S; White, CM | 1 |
| Baicu, SC; Crawford, FA; de Gasparo, M; Hendrick, JW; King, MK; Loging, JA; New, RB; Spinale, FG | 1 |
2 trial(s) available for valsartan and Postoperative Complications
| Article | Year |
|---|---|
Benefits of early administration of Sacubitril/Valsartan in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anterior Wall Myocardial Infarction; Biphenyl Compounds; Drug Combinations; Drug Monitoring; Early Medical Intervention; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Percutaneous Coronary Intervention; Postoperative Complications; Stroke Volume; Treatment Outcome; Valsartan | 2021 |
Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diastole; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Placebos; Postoperative Complications; Safety; Systole; Tetrazoles; Valine; Valsartan | 2006 |
4 other study(ies) available for valsartan and Postoperative Complications
| Article | Year |
|---|---|
Late lumen loss and follow-up percent diameter stenosis at different doses of oral valsartan six months after bare-metal stent implantation in type B2/C coronary lesions.
Topics: Administration, Oral; Aged; Cohort Studies; Coronary Restenosis; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Postoperative Complications; Stents; Tetrazoles; Time Factors; Valine; Valsartan | 2010 |
Effect of valsartan on urinary protein excretion and renal function in patients with chronic renal allograft nephropathy.
Topics: Adult; Aged; Antihypertensive Agents; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Potassium; Proteinuria; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Biphenyl Compounds; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Irbesartan; Lisinopril; Male; Postoperative Complications; Ramipril; Retrospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
Effects of angiotensin type-I receptor blockade on pericardial fibrosis.
Topics: Angiotensin Receptor Antagonists; Animals; Cardiac Surgical Procedures; Collagen; Fibrosis; Hydroxyproline; Male; Pericardium; Postoperative Complications; Receptors, Angiotensin; Reoperation; Swine; Tetrazoles; Valine; Valsartan | 1999 |